Atomic force microscopy study of the antimicrobial action of Sushi peptides on Gram negative bacteria  by Li, A. et al.
a 1768 (2007) 411–418
www.elsevier.com/locate/bbamemBiochimica et Biophysica ActAtomic force microscopy study of the antimicrobial action of
Sushi peptides on Gram negative bacteria
A. Li a, P.Y. Lee a, B. Ho b, J.L. Ding c,e, C.T. Lim a,d,e,⁎
a Department of Mechanical Engineering, National University of Singapore, Singapore
b Department of Microbiology, National University of Singapore, Singapore
c Department of Biological Sciences, National University of Singapore, Singapore
d Division of Bioengineering, National University of Singapore, Singapore
e Singapore-MIT Alliance II, Computational Systems Biology (Immunology and Tissue Defense Flagship Research Programme), Singapore
Received 5 July 2006; received in revised form 7 December 2006; accepted 11 December 2006
Available online 21 December 2006Abstract
The antibacterial effect of the endotoxin-binding Sushi peptides against Gram-negative bacteria (GNB) is investigated in this study. Similar
characteristics observed for Atomic force microscopy (AFM) images of peptide-treated Escherichia coli and Pseudomonas aeruginosa suggest
that the Sushi peptides (S3) evoke comparable mechanism of action against different strains of GNB. The results also indicate that the Sushi
peptides appear to act in three stages: damage of the bacterial outer membrane, permeabilization of the inner membrane and disintegration of both
membranes. The AFM approach has provided vivid and detailed close-up images of the GNB undergoing various stages of antimicrobial peptide
actions at the nanometer scale. The AFM results support our hypothesis that the S3 peptide perturbs the GNB membrane via the “carpet-model”
and thus, provide important insights into their antimicrobial mechanisms.
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Bacterial resistance to traditional antibiotics has been on an
increase [1,2]. As such, there is a need for a novel family of
antimicrobial drugs. Antimicrobial peptides show good pro-
spects for this family as their postulated mechanism of action is
unlike that of traditional antibiotics [3,4]. Although many of
such peptides have been worked on, their exact mechanisms of
action are still under exploration [5–10]. Nevertheless, it is
postulated that these peptides probably possess the same
mechanism(s) of antimicrobial action and that they in particular
act by targeting the bacterial membrane [11,12]. The cationic
peptides first bind to negatively charged lipopolysaccharide
(LPS) of Gram negative bacteria (GNB) [11–15]. This binding
may cause membrane penetration in a variety of ways: (a) slight
disturbance of phospholipid chain order and packing in the⁎ Corresponding author. Tel.: +65 6516 7801; fax: +65 6779 1459.
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doi:10.1016/j.bbamem.2006.12.010outer membrane (self-promoted uptake model) [13]; (b)
transmembrane channel creation (barrel-stave or toroidal pore
model) [16]; (c) damage of the bilayer via toroidal pores,
disruption of lipid micelles and vesicles via the “carpet model”
[12,17–19]; or (d) creation of micelle-like accumulation of
peptides in the membrane (peptide-aggregate model) [3]. All
these modes of action eventually kill the bacteria.
The horseshoe crab has a powerful innate immune system.
During infection, the bacterial LPS activates Factor C to
trigger a coagulation cascade in the horseshoe crab [20].
Factor C acts as a biosensor [2,20] which reacts to pg levels
of LPS [4,20]. The LPS binding motif(s) of Factor C show
extremely high affinity for LPS [21–23]. Close to the N-
terminus of the multidomain Factor C molecule [24], are a
number of repeating units of Sushi domains of ∼60 amino
acids each, which bind the LPS. The LPS binding region of
Sushi 3 has been defined within a 34-mer peptide, hereafter
referred to as S3. S3 has been shown to bind and kill GNB
[25]. Akin to most antimicrobial peptides, the mechanism of
Fig. 1. Images of untreated E. coli and P. aeruginosa (the left panels show deflection images and the right panels are 3D reconstructions based on height data). (A)
10×10 μm scan size image of untreated E. coli. (B) 5×5 μm scan size image of single untreated E. coli. (C) 500×500 nm closeup image showing the rough surface of
the E. coli. (D) 4×4 μm scan size image of an untreated P. aeruginosa.
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earlier study proposed that the capability of the S3 dimer to
attach to LPS micelles enables it to preferentially perturb the
bacterial membrane [4,26] and disrupt the fluidic integrity of
the bacterial membrane by the ‘carpet model’ [26]. Being
non-cytotoxic [22] and non-hemolytic [25] to the host, S3 is
an excellent antimicrobial peptide candidate.
Atomic force microscope (AFM) is a powerful imaging tool
which is capable of achieving high resolution images of
biological samples even under physiological conditions such as
in fluid and at physiological temperature. The usefulness of
AFM to study antimicrobial peptide mechanisms has been
proven through a series of experiments either on model
membrane or intact cells [27–31].
Based on the above understanding which used LPS micelles
and LPS vesicles in vitro, we further examined the antimicrobial
mechanism of action of S3 against the whole bacteria. AFM isFig. 2. Gram negative bacteria which have undergone 26 h incubation in distille
reconstructions). (A) E. coli. (B) P. aeruginosa. The arrow indicates a lysed cell inemployed to image the peptide-treated bacteria. The AFM
images obtained have provided significant insights into how S3
perturbs GNB.2. Materials and methods
2.1. Peptides
Peptides used in this study were synthesized and purified to >95% purity by
Genemed Synthesis Inc. (San Francisco, CA). The native S3 peptide, N-
HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM-C, with a molecular
weight of 3,892, corresponds to residues 268–301 of the Factor C Sushi 3
domain (GenBankTM/EBI accession number S77063).
2.2. Bacteria
Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853
were grown overnight at 37 °C in nutrient broth (Oxoid).d water (the left panels show deflection images and the right panels are 3D
panel B.
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E. coli and P. aeruginosa were resuspended in deionized distilled water
and equal volumes of S3 and bacteria were incubated in depyrogenised
borosilicate tubes for durations of 1, 5, 15, 30 and 60 min at room
temperature. The initial bacterial populations were kept constant at 106 cfu/
ml, while varying concentrations of S3 were used, namely 0.25, 0.5, 1.0, and
5.0 μM, in the reaction mixtures. After incubation, the peptide-treated
bacterial suspensions were applied onto poly-L-lysine pretreated glass slides
and air dried in a vacuum desiccator. Control untreated bacteria were
similarly prepared within 2 h of being resuspended in distilled water.
Overnight cultures in the distilled water were also tested to exclude the
possible osmotic effect by water.
2.4. AFM analysis
Imaging was performed with a Nanoscope III Dimension 3100 AFM
(Digital Instruments, Santa Barbara, CA). Standard silicon AFM cantilevers,
OTR8, with spring constant of 0.15 N/m, and a nominal tip radius of <20 nm
were used to image both the controls and peptide-treated bacteria. The samplesFig. 3. Indentations and outer membrane debris (arrows) found on and around GNBs t
the right panels are 3D reconstructions). (A) E. coli treated with 0.25 μM of S3 forwere imaged in air using the contact mode with settings of 512 pixels/line and
1 Hz scan rate. Some of the images were first order flattened and contrast
enhanced using Nanoscope 5.13 for better demonstration on details.3. Results and discussion
3.1. AFM images of control E. coli and P. aeruginosa
The AFM images of freshly prepared untreated E. coli
showed characteristic rod shape with the distinctive peritrichous
flagella and pili structures (Fig. 1A, B). The cell surface
displayed roughness similar to that observed by Ricci et al. [30]
(Fig. 1C).
The AFM images of freshly prepared P. aeruginosa also
showed rod shape cell with polar-monotrichous flagellum on
the cell. The surface is comparatively smooth compared with E.
coli (Fig. 1D).reated with low concentration peptide (the left panels show deflection images and
15 min. (B) P. aeruginosa: treated with 0.25 μM of S3 for 15 min.
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morphology of bacteria, we incubated both E. coli and P.
aeruginosa in distilled water for 2 h (within the range of
duration of peptide treatment), 26 h and 48 h. Results
indicated that only slight dehydration and indentation were
observed on the cells (Fig. 2). Furthermore, some lysed cells
were observed after 26 and 48 h incubation but their
morphologies were distinctly different from those treated by
S3 peptide (Fig. 2B).
3.2. AFM images of low concentration S3 treated E. coli and
P. aeruginosa
At the low concentrations of S3 (0.25, 0.5, 1 μM), the initial
morphological changes observed are that of indentations
appearing on the surface of some cells as well as some
micelle-like structures or outer membrane residues foundFig. 4. Small amount of leakage of periplasmic fluid found at the apical end of GNB
and the right panels are 3D reconstructions). (A) E. coli treated with 0.5 μM of S3around the cells (Fig. 3). This indicates the disruption of the
outer membrane of the bacteria, probably due to direct
interaction and binding of S3 to the LPS. This perturbation
may have damaged the outer membrane, thus exposing the
peptidoglycan wall beneath it. This observation is consistent
with that made by Da Silva et al. [31], where the E. coli was
treated with the antimicrobial peptide PGLa. It supports the
hypothesis that S3 preferentially reacts with LPS micelles
aggregated on GNB outer membrane and perturbs the
membrane by the “carpet-model” [26].
The next stage of morphological change arising from low
concentration treatment is shown in Fig. 4. Some fluid and
debris can be observed around the apical end of the cells. As can
be seen from Fig. 4B, the outer membrane collapsed while the
inner part of the cell still remained intact. It is postulated that the
debris originates from the bacterial periplasm. S3 first binds to
negatively charged LPS of GNB to enable its initial penetrationtreated with lower concentration of peptide (the left panels are deflection images
for 30 min. (B) P. aeruginosa treated with 0.25 μM of S3 for 30 min.
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the periplasmic material. Also, leakage of fluid was found to be
at the poles of the bacteria. Thus, it is possible that the apical
ends are where the bacteria are being targeted first, or where the
damage is first concentrated. This is logical since the domains of
cardiolipin (a negatively charged phospholipid) reside at the
apical ends of E. coli inner membrane (other than the septal
regions) [32]. S3 is highly cationic and would have greater
affinity for negatively charged phospholipids [4,26,33]. Hence,
it is probable that the peptide concentrated at the apical ends,
which initiated the cell leakage.
3.3. AFM images of higher concentration of S3 treated E. coli
and P. aeruginosa
Fig. 5 shows AFM images of the bacteria exposed to a higher
peptide concentration of 5μM for a short period of time. TheFig. 5. Extensive leakage of cytoplasmic fluid from the partially disintegrated GNB
deflection images and the right panels are 3D reconstructions). (A) E. coli treated winitial reaction is the leakage of large amount of fluid from the
partially disintegrated cells. It is probably the cytoplasmic fluid
that had leaked out from the inner membrane of the cell. This
indicates that the peptides had caused damage to the bacterial
inner membrane.
When exposed to high S3 peptide concentration of 5 μM for
a longer period of time, Fig. 6 shows copious amount of
cytoplasmic fluid exuded from the bacteria. These bacteria
appear either severely damaged or their membrane fully
collapsed. This indicates drastic permeabilization of the inner
membrane. It is suspected that S3 binds to the LPS on the outer
cell wall but at higher concentration, there appears to be a
speeding up of events as the peptides are known to show co-
operativity of binding with their target ligand to result in such
aggregation of the bacteria [4,26].
In summary, the action of S3 can be classified into three
stages. In the initial stage, S3 damaged the bacterial outers when exposed to 5 μM of S3 for a short period of time (the left panels show
ith 5 μM of S3 for 5 min. (B) P. aeruginosa treated with 5 μM of S3 for 1 min.
Fig. 6. Severely damaged GNBs with cell debris as well as large amount of exuded cytoplasmic fluid from bacteria treated with 5 μM S3 peptide (the left panels are
deflection images and the right panels are 3D reconstructions). (A) E. coli treated with 5 μM of S3 for 1 h. (B) P. aeruginosa treated with 5 μM of S3 for 30 min.
Arrows indicate the outlines of lysed cells.
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formation of LPS micelles. This supports the “carpet-like”
mechanism, which had been proposed to account for the action
of S3 in an earlier study [26]. The indentations on the cells as
well as the debris and small amount of fluid found around the
damaged cells suggest that the outer membrane and peptido-
glycan wall structures were affected by the action of S3. In the
second stage, permeabilization of the inner membrane was
initiated, leading to the leakage of cytoplasmic fluid. Further
membrane damage resulted in large losses of cytoplasmic fluid.
Being devoid of intracellular fluid and organelles, the cell
architectural support was compromised and hence the bacteria
collapsed. In the third stage, the cell membranes were
disintegrated, leaving behind massive amounts of membrane
residues or debris. Only bacteria exposed to high concentrations
of S3 showed the characteristics of the last stage.Here, the samples were air dried and then imaged using AFM
at different time points of treatment with S3 peptide. However,
using this endpoint protocol, the dynamic morphological
changes induced by the peptide were lacking. This may only
be resolved by visualising the membrane perturbation using
real-time AFM. Nevertheless, the AFM approach here is still
able to provide substantially vivid and detailed close-up images
of the GNBs undergoing the various stages of antimicrobial
peptide actions, down to the nanometer scale and hence, gives
further important insights into the antimicrobial mechanisms
involved.
4. Conclusions
For the first time, an antimicrobial LPS-binding peptide, S3,
has been studied on two different species of Gram negative
418 A. Li et al. / Biochimica et Biophysica Acta 1768 (2007) 411–418bacteria, E. coli and P. aeruginosa. The AFM results obtained
suggest that the mechanism of antimicrobial actions of S3 is
comparable for both E. coli and P. aeruginosa and can be
classified into three stages: damage of the bacterial outer
membrane, permeabilization of the inner membrane and
disintegration of both membranes and spillage of cytoplasm.
The morphological effects seen in both of the bacteria are vivid
and dramatic. The results of this study are consistent with and
validates earlier studies where different biochemical and
biophysical approaches were used.
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